Cite

HARVARD Citation

    Jin, Y. et al. (2021). Development of CpG oligodeoxynucleotide TLR9 agonists in anti-cancer therapy. Expert review of anticancer therapy. 21 (8), pp. 841-851. [Online]. 
  
Back to record